Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financial Officer

SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the appointment of Christine Silverstein as Chief Financial Officer. Silverstein joins Excision with more than 15 years of financial leadership and capital markets expertise in the biopharmaceutical industry. “We […]

InterVenn Biosciences Announces That Arnold Levine Has Joined the Company’s Board of Advisors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced that Arnold Levine, Ph.D., has joined the Company’s Board of Advisors, effective March 19, 2021. Dr. Levine joins the InterVenn Board of Advisors as one of the pioneers of molecular cancer research. Dr. Levine and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor […]